These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Thyrotropin receptor antibodies detected by the human recombinant TBII assay--a surrogate marker for autoimmune activity in Graves' ophthalmopathy? Myśliwiec J; Kretowski A; Stepień A; Mirończuk K; Kinalska I Med Sci Monit; 2002 Sep; 8(9):MT159-62. PubMed ID: 12218953 [TBL] [Abstract][Full Text] [Related]
8. Relevance of TSH receptor stimulating and blocking autoantibody measurement for the prediction of relapse in Graves' disease. Schott M; Minich WB; Willenberg HS; Papewalis C; Seissler J; Feldkamp J; Bergmann A; Scherbaum WA; Morgenthaler NG Horm Metab Res; 2005 Dec; 37(12):741-4. PubMed ID: 16372227 [TBL] [Abstract][Full Text] [Related]
9. The thyroid "microsomal" antigen is an epitope on the thyrotropin receptor. Islam N; Tuppal R; Hawe BS; Briones-Urbina R; Farid NR J Cell Biochem; 1986; 31(2):107-20. PubMed ID: 2426288 [TBL] [Abstract][Full Text] [Related]
10. Determination of the levels of anti-thyroid-stimulating hormone receptor antibody with thyroid peroxidase antibody in Omani patients with Graves' disease. Alnaqdy A; Al-Maskari M Med Princ Pract; 2005; 14(4):209-12. PubMed ID: 15961927 [TBL] [Abstract][Full Text] [Related]
11. Hepatic dysfunction related to thyrotropin receptor antibody in patients with Graves' disease. He K; Hu Y; Xu XH; Mao XM Exp Clin Endocrinol Diabetes; 2014 Jun; 122(6):368-72. PubMed ID: 24941434 [TBL] [Abstract][Full Text] [Related]
12. Dendritic cells in Graves' disease. Purnamasari D; Soewondo P; Djauzi S Acta Med Indones; 2015 Jan; 47(1):61-9. PubMed ID: 25948770 [TBL] [Abstract][Full Text] [Related]
13. High frequency of B cells capable of producing anti-thyrotropin receptor antibodies in patients with Graves' disease. Fan JL; Desai RK; Dallas JS; Wagle NM; Seetharamaiah GS; Prabhakar BS Clin Immunol Immunopathol; 1994 Apr; 71(1):69-74. PubMed ID: 8137560 [TBL] [Abstract][Full Text] [Related]
14. Characteristics of patients with graves disease and intrathyroid hypovascularity compared to painless thyroiditis. Uchida T; Shigihara N; Takeno K; Komiya K; Goto H; Abe H; Sato J; Honda A; Fujitani Y; Watada H J Ultrasound Med; 2014 Oct; 33(10):1791-6. PubMed ID: 25253825 [TBL] [Abstract][Full Text] [Related]
15. Erratic movement disorders disclosing Graves' disease and paralleling thyroid function but not autoantibody levels. Delhasse S; Debove I; Arnold-Kunz G; Ghika JA; Chabwine JN J Int Med Res; 2019 Mar; 47(3):1378-1386. PubMed ID: 30761931 [TBL] [Abstract][Full Text] [Related]
16. Thyroid-stimulating antibodies of Graves' disease in thyroid cancer. Röher HD; Goretzki PE; Frilling A N Engl J Med; 1988 Dec; 319(25):1669-70. PubMed ID: 3200284 [No Abstract] [Full Text] [Related]
17. Significant attenuation of stimulated cortisol in early Graves disease without adrenal autoimmunity. Price SA; Thondam S; Bondugulapati LN; Kamath C; Adlan M; Premawardhana LD Endocr Pract; 2012; 18(6):924-30. PubMed ID: 22982787 [TBL] [Abstract][Full Text] [Related]
18. The value of color flow Doppler ultrasonography of the superior thyroid artery in the surgical management of Graves disease. Huang SM; Chow NH; Lee HL; Wu TJ Arch Surg; 2003 Feb; 138(2):146-51; discussion 151. PubMed ID: 12578408 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of human foamy virus-related sequences in the Korean population. Lee H; Kim S; Kang M; Kim W; Cho B J Biomed Sci; 1998; 5(4):267-73. PubMed ID: 9691219 [TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies with thyroid stimulating activity, at last. Costagliola S; Vassart G Thyroid; 2002 Dec; 12(12):1039-41. PubMed ID: 12593716 [No Abstract] [Full Text] [Related] [Next] [New Search]